About this trial
The ARCH programme is a novel, strength-based, dyadic, multicomponent psychosocial intervention that blends together psychoeducation, psychosocial support and self-compassion practices to aid first-time stroke survivors and their family caregivers with their psycho-socio-emotional and spiritual challenges following discharge from in-patient care. A pre-post experimental design with a feasibility and acceptability assessment is adopted to evaluate and refine the ARCH intervention in promoting wellbeing, self-compassion, independence, quality of life, hope, resilience, self-efficacy and dyadic mutuality.
Eligibility criteria
Qualifiers
Aged 21 years and above
Recovering from their first stroke at mild to moderate degree of severity
Discharged from inpatient care at no later than 3 months,
Clinically assessed to have cognitive capacities to engage in and complete the research study,
Disqualifiers
Families with survivors suffering from aphasia,
Being too ill to participate,
Experiencing moderate to severe cognitive impairment, and
With family caregivers who are not interested to participate.
Trial design
Treatments tested in this trial
- Pre-Post ARCH Intervention
Treatment groups
Sponsors and collaborators
Nanyang Technological University
Lead sponsor
Tan Tock Seng Hospital
Collaborator